25
Views
9
CrossRef citations to date
0
Altmetric
Research Article

Regulatory Mechanisms in the Activation of Nitrogenous Compounds by Mammalian Cytochrome P-450 Isozymes

Pages 325-348 | Published online: 22 Sep 2008

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Yingying Guo, Linda L. Breeden, Helmut Zarbl, Bradley D. Preston & David L. Eaton. (2005) Expression of a Human Cytochrome P450 in Yeast Permits Analysis of Pathways for Response to and Repair of Aflatoxin-Induced DNA Damage. Molecular and Cellular Biology 25:14, pages 5823-5833.
Read now

Articles from other publishers (6)

Joseph Locker. 2015. Liver Regeneration. Liver Regeneration 199 212 .
Patrik Rydberg, Martin S. Jørgensen, Thomas A. Jacobsen, Anne-Marie Jacobsen, Kim G. Madsen & Lars Olsen. (2013) Nitrogen Inversion Barriers Affect the N-Oxidation of Tertiary Alkylamines by Cytochromes P450. Angewandte Chemie International Edition 52:3, pages 993-997.
Crossref
Patrik Rydberg, Martin S. Jørgensen, Thomas A. Jacobsen, Anne‐Marie Jacobsen, Kim G. Madsen & Lars Olsen. (2012) Nitrogen Inversion Barriers Affect the N‐Oxidation of Tertiary Alkylamines by Cytochromes P450. Angewandte Chemie 125:3, pages 1027-1031.
Crossref
Peter Hlavica. (2006) Functional interaction of nitrogenous organic bases with cytochrome P450: A critical assessment and update of substrate features and predicted key active-site elements steering the access, binding, and orientation of amines. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics 1764:4, pages 645-670.
Crossref
Katja K.H. Aben, Jacqueline Cloos, Norbert P. Koper, Boudewijn J.M. Braakhuis, J. Alfred Witjes & Lambertus A.L.M. Kiemeney. (2000) Mutagen sensitivity in patients with familial and non-familial urothelial cell carcinoma. International Journal of Cancer 88:3, pages 493-496.
Crossref
J. Cloos, C.B.A. Reid, G.B. Snow & B.J.M. Braakhuis. (1996) Mutagen sensitivity: Enhanced risk assessment of squamous cell carcinoma. European Journal of Cancer Part B: Oral Oncology 32:6, pages 367-372.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.